Synonyms: Arelili® | Ariely® | HTI-1088 | HTI1088 | SHR-1316 | SHR1316
adebrelimab is an approved drug (China NMPA (2023))
Compound class:
Antibody
Comment: Adebrelimab (SHR-1316; HTI-1088) is a chimeric humanized IgG4κ anti-PD-L1 monoclonal antibody.
|
Bioactivity Comments |
The killing effect of SHR-1316 on breast cancer cells has been demonstated in vitro [1]. |
Selectivity at ligand targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|